SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Stock Price Down 1.2% – Should You Sell?

SWEDISH ORPHAN/S (OTCMKTS:SWTUYGet Free Report)’s share price was down 1.2% during mid-day trading on Wednesday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares traded hands during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.

SWEDISH ORPHAN/S Stock Performance

The stock’s 50 day simple moving average is $24.38 and its 200-day simple moving average is $24.38. The firm has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81.

About SWEDISH ORPHAN/S

(Get Free Report)

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.

Featured Stories

Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.